Categories
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
751
Antibiotics
271
Bioactive Small Molecules
799
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2162
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
24
Ligands
81
Organics
1628
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
27
Water Analysis
13
Ciclopirox olamine
(21723158 | 41621-49-2)
CAS: | 41621-49-2 |
---|---|
Molecular Formula: | C12H17NO2 · C2H7NO |
Molecular Weight: | 268.35 |
Availablility: | In Stock |
---|---|
Downloads: | | |
This product is subject to a hazardous surcharge. The exact amount will be confirmed by our sales team.
21723158-1g | 1g | £37.30 | |
Bulk Order |
21723158-1g | 1g | €52.30 | |
Bulk Order |
21723158-1g | 1g | $56.00 | |
Bulk Order |
Safety Data Sheet
Certificate of Analysis
Product Detail
Product Code | 21723158 | ||||
Product Name | Ciclopirox olamine | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 41621-49-2 | ||||
Molecular Formula | C12H17NO2 · C2H7NO | ||||
Molecular Weight | 268.35 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 2933790090 |
Product Specification
pH | 8.0-9.0 | ||||
Loss on Drying | ≤1.0% | ||||
Assay | ≥99% | ||||
Residue on Ignition | ≤0.1% | ||||
Appearance | White/ off white powder | ||||
Melting Range | 124.0-128.0 °C | ||||
Heavy metal content | ≤20 ppm |
Safety Information
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|